Let s Add a New Beast to the Lore of Wall Street
Posted March 9, 2021
Wall Street is known for its animal lore: “Bulls make money, bears make money, and pigs get slaughtered” is the hoary old saying.
Recently, financial writer Jason Zweig suggested we add the bonasus.
I second this motion wholeheartedly. And to be honest, I had to look up the beast myself.
According to Pliny the Elder in his
Naturalis Historia:
There are reports of a wild animal in Paionia called the bonasus, which has the mane of a horse, but in all other respects resembles a bull; its horns are curved back in such a manner as to be of no use for fighting, and it is said that because of this it saves itself by running away, meanwhile emitting a trail of dung that sometimes covers a distance of as much as three furlongs, contact with which scorches pursuers like a sort of fire.
Lockdown bremst Auto-Markterholung in Deutschland aus
tichyseinblick.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tichyseinblick.de Daily Mail and Mail on Sunday newspapers.
Neuzulassungen deutlich unter dem Vorjahr :: motor-traffic
motor-traffic.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from motor-traffic.de Daily Mail and Mail on Sunday newspapers.
EU nightmare: Bloc s future ripped apart as it will only become more dysfunctional Joel Day
Replay Video UP NEXT
Brussels faltered this week at one of the most important hurdles in tackling Europe s coronavirus pandemic. The bloc fell significantly behind countries like Britain in rolling out its mass vaccine programme, after what was blamed on Brussels bureaucracy . Doses from the pharmaceutical company AstraZeneca, developed at the University of Oxford, left production facilities in Belgium and the Netherlands and headed for the UK, much to the dismay of the neighbouring countries.
In response, European Commission President Ursula von der Leyen threatened to cut those vaccines from the UK, insisting that the EU had a contract with AstraZeneca that should be upheld before doses leave the continent.